Priority Date: 24.02.16 (US 201662299543P)

METHODS OF TREATING CELIAC DISEASE USING SMAD7 INHIBITION

  • Application ID: EP17709605
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Kilburn & Strode LLP is specialized in C12. Kilburn & Strode LLP is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 24.02.2016 - Priority Date (US 201662299543P)
  • 31.08.2017 - Publication A1 (WO2017144689)
  • 02.01.2019 - Publication A1 (EP3420085)

IPC Classification